Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria

  1. Alexandre Chojnowski
  2. Peh Fern Ong
  3. Esther SM Wong
  4. John SY Lim
  5. Rafidah A Mutalif
  6. Raju Navasankari
  7. Bamaprasad Dutta
  8. Henry Yang
  9. Yi Y Liow
  10. Siu K Sze
  11. Thomas Boudier
  12. Graham D Wright
  13. Alan Colman
  14. Brian Burke
  15. Colin L Stewart
  16. Oliver Dreesen  Is a corresponding author
  1. Institute of Medical Biology, Singapore
  2. Nanyang Technological University, Singapore
  3. National University of Singapore, Singapore
  4. IPAL UMI 2955, Singapore

Abstract

Hutchinson-Gilford progeria (HGPS) is a premature ageing syndrome caused by a mutation in LMNA, resulting in a truncated form of lamin A called progerin. Progerin triggers loss of the heterochromatic marker H3K27me3, and premature senescence, which is prevented by telomerase. However, the mechanism how progerin causes disease remains unclear. Here, we describe an inducible cellular system to model HGPS and find that LAP2α (lamina-associated polypeptide-α) interacts with lamin A, while its interaction with progerin is significantly reduced. Super-resolution microscopy revealed that over 50% of telomeres localize to the lamina and that LAP2α association with telomeres is impaired in HGPS. This impaired interaction is central to HGPS since increasing LAP2α levels rescues progerin-induced proliferation defects and loss of H3K27me3, whereas lowering LAP2 levels exacerbates progerin-induced defects. These findings provide novel insights into the pathophysiology underlying HGPS, and how the nuclear lamina regulates proliferation and chromatin organization.

Article and author information

Author details

  1. Alexandre Chojnowski

    Developmental and Regenerative Biology, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  2. Peh Fern Ong

    Cellular Ageing, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  3. Esther SM Wong

    Developmental and Regenerative Biology, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  4. John SY Lim

    Microscopy Unit, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  5. Rafidah A Mutalif

    Developmental and Regenerative Biology, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  6. Raju Navasankari

    Developmental and Regenerative Biology, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  7. Bamaprasad Dutta

    School of Biological Sciences, Nanyang Technological University, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  8. Henry Yang

    Bioinformatics Core, Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  9. Yi Y Liow

    Developmental and Regenerative Biology, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  10. Siu K Sze

    School of Biological Sciences, Nanyang Technological University, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  11. Thomas Boudier

    Bioinformatics Institute, IPAL UMI 2955, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  12. Graham D Wright

    Microscopy Unit, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  13. Alan Colman

    Stem Cell Disease Models, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  14. Brian Burke

    Nuclear Dynamics and Architecture, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  15. Colin L Stewart

    Developmental and Regenerative Biology, Institute of Medical Biology, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  16. Oliver Dreesen

    Cellular Ageing, Institute of Medical Biology, Singapore, Singapore
    For correspondence
    oliver.dreesen@imb.a-star.edu.sg
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (140960) of the Institute of Medical Biology, A*STAR, Singapore.

Copyright

© 2015, Chojnowski et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,523
    views
  • 1,211
    downloads
  • 102
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alexandre Chojnowski
  2. Peh Fern Ong
  3. Esther SM Wong
  4. John SY Lim
  5. Rafidah A Mutalif
  6. Raju Navasankari
  7. Bamaprasad Dutta
  8. Henry Yang
  9. Yi Y Liow
  10. Siu K Sze
  11. Thomas Boudier
  12. Graham D Wright
  13. Alan Colman
  14. Brian Burke
  15. Colin L Stewart
  16. Oliver Dreesen
(2015)
Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria
eLife 4:e07759.
https://doi.org/10.7554/eLife.07759

Share this article

https://doi.org/10.7554/eLife.07759

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Steven Henikoff, David L Levens
    Insight

    A new method for mapping torsion provides insights into the ways that the genome responds to the torsion generated by RNA polymerase II.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bhumil Patel, Maryke Grobler ... Needhi Bhalla
    Research Article

    Meiotic crossover recombination is essential for both accurate chromosome segregation and the generation of new haplotypes for natural selection to act upon. This requirement is known as crossover assurance and is one example of crossover control. While the conserved role of the ATPase, PCH-2, during meiotic prophase has been enigmatic, a universal phenotype when pch-2 or its orthologs are mutated is a change in the number and distribution of meiotic crossovers. Here, we show that PCH-2 controls the number and distribution of crossovers by antagonizing their formation. This antagonism produces different effects at different stages of meiotic prophase: early in meiotic prophase, PCH-2 prevents double-strand breaks from becoming crossover-eligible intermediates, limiting crossover formation at sites of initial double-strand break formation and homolog interactions. Later in meiotic prophase, PCH-2 winnows the number of crossover-eligible intermediates, contributing to the designation of crossovers and ultimately, crossover assurance. We also demonstrate that PCH-2 accomplishes this regulation through the meiotic HORMAD, HIM-3. Our data strongly support a model in which PCH-2’s conserved role is to remodel meiotic HORMADs throughout meiotic prophase to destabilize crossover-eligible precursors and coordinate meiotic recombination with synapsis, ensuring the progressive implementation of meiotic recombination and explaining its function in the pachytene checkpoint and crossover control.